BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

The poster presented data from AUTX-703, a potent, selective and orally bioavailable heterobifunctional degrader of KAT2A/B, an AURIGIN-identified histone acetyltransferase driving small cell lung ...

Compelling preclinical data in models of both GBA1-PD and idiopathic PD, demonstrating a disease-modifying effect after ...

Ashvamedha - 2K25, a one-day management fest with various competitions for graduate students at KLES Engineering College.

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

The Science Association of St. Xavier’s College (Autonomous), Kolkata, proudly presents Sigma 2025, its Annual Flagship Event ...

One-click Background Change: With just a click, change the background of any product image. Ideal for beginners, it provides a sophisticated yet simple solution. User-Friendly Interface: Simply upload ...

Lab network revenue increased by 33% year over year, reflecting strong demand for ColoAlert® in Europe Operating loss ...

Dolan’s grievances with the NBA and its commissioner Adam Silver have continued to mount. What could come next?